Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,192 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07524205Recruiting
Activity and glucose tracking to reduce sitting in older adults with type 2 diabetes
This study helps older adults with type 2 diabetes understand how their blood sugar and daily activity are connected. You'll wear devices that track your glucose (blood sugar) and movement, and the research team will use this information to help you sit less and move more.
Minneapolis, MinnesotaAges 55 years+ - NCT07528105RecruitingEarly Phase 1
CAR-T Cell Therapy for Early-Stage Type 1 Diabetes
This early-stage trial tests a new type of immune cell therapy (CAR-T cells) designed to stop the body's immune system from attacking insulin-producing cells in type 1 diabetes. The goal is to help preserve remaining pancreas function in people with early-stage disease.
ShanghaiAges 18–40 - NCT07531459Recruiting
Understanding Health Behaviors in Type 2 Diabetes
This study is creating and testing a new tool to measure healthy behaviors in people with type 2 diabetes. Researchers want to understand how patients manage their diabetes day-to-day and how healthcare workers can better support them.
Changzhou, JiangsuAges 18 years+ - NCT07546929RecruitingPhase 2
HP-211 Safety Study for Type 2 Diabetes Treatment
This study tests a new medicine called HP-211 in people with early-stage type 2 diabetes to see if it's safe and helps control blood sugar. You'd take the study drug along with your current diabetes management.
Canoga Park, CaliforniaAges 18 years+ - NCT07556497Recruiting
Blood cells and inflammation in diabetic heart disease
This study looks at why people with type 2 diabetes develop heart problems. Researchers will examine special cells in your blood and inflammation markers to better understand these complications.
DohaAges 18 years+ - NCT07564414RecruitingPhase 3
Weight Loss Study Comparing Two Doses of CagriSema
This study tests whether a new combination medication called CagriSema (in two different doses) helps people with obesity lose weight. You may qualify if you're 18 or older, have a BMI of 35 or higher, and either don't have type 2 diabetes or have it well-controlled.
Birmingham, AlabamaAges 18 years+ - NCT07574333Recruiting
Breathing Training to Help Type 2 Diabetes Management
This study tests whether special breathing exercises that alternate between low and high oxygen levels can help people with type 2 diabetes manage their condition better. Researchers want to see if short or longer courses of this training improve blood sugar control and overall health.
MoscowAges 50–74 - NCT07578584RecruitingPhase 1
Safety study of NNC0497-0040 in healthy and overweight adults
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
NeussAges 18–55 - NCT07581145RecruitingPhase 3
Semaglutide for Faster Healing of Diabetic Foot Ulcers
This study tests whether a diabetes medication called semaglutide can help foot ulcers heal faster in people with type 2 diabetes. If it works, it could offer a new treatment option for a common and serious diabetes complication.
CopenhagenAges 18–90 - NCT07649967Recruiting
Mixed Reality Balance and Movement Tests for Type 2 Diabetes
This study tests whether new virtual-reality-based balance and movement tests work well for people with type 2 diabetes. Researchers want to see if these tests can safely and accurately measure how well people can move and balance.
Konya, SelcukluAges 18–65 - NCT07658755Recruiting
LiverSeek: Finding advanced liver scarring in MASLD
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
Madrid, MadridAges 50–75 - NCT07659535Recruiting
Digital tool to prevent type 2 diabetes
This trial tests a digital lifestyle tool combined with a large language model to help prevent type 2 diabetes. It's for adults in Sweden who are at risk but don't already have diabetes.
Malmö, Skåne CountyAges 35 years+ - NCT07659925Recruiting
Strength training with changing levels for type 2 diabetes
This study tests whether a special strength-training program, designed with changing exercise levels (periodization), can help people with type 2 diabetes improve their blood sugar control and overall fitness. It is a good option for adults with diabetes who are not currently in a regular exercise routine.
Ankara, AnkaraAges 18–65 - NCT07665567Enrolling by invitation
Helping reverse type 2 diabetes with lifestyle changes and monitoring
This study tests if a coaching program focused on diet, activity, and blood sugar tracking can help people with early type 2 diabetes put their diabetes into remission. You'll receive guidance and tools to manage your health and potentially reduce or stop diabetes medications.
Hamilton, OntarioAges 30–80 - NCT07642830Enrolling by invitation
Digital Health Tools for Type 2 Diabetes Management
This study tests a smartphone-based digital health system designed to help people with type 2 diabetes manage their condition better. The program uses technology on your phone to support your diabetes care over time.
Taoyuan, TaiwanAges 20–75 - NCT07598773Enrolling by invitation
Continuous glucose monitoring study for prediabetes and type 2 diabetes
This study asks you to wear a glucose monitor and smart ring for several months to help researchers understand how blood sugar changes throughout the day in people with prediabetes or type 2 diabetes. The goal is to learn how lifestyle and medications affect blood sugar control.
San Francisco, CaliforniaAges 18 years+ - NCT07452913Enrolling by invitationPhase 4
Comparing Diabetes Drug Combinations in Newly Treated Adults
This trial compares two different combinations of diabetes pills (metformin plus empagliflozin with either sitagliptin or linagliptin) in people with type 2 diabetes who have not been treated before. It aims to see which combination works better and is safer for controlling blood sugar.
Karachi, SindhAges 30–55 - NCT07394075Enrolling by invitation
CGM support for type 2 diabetes management
This trial tests whether using continuous glucose monitor (CGM) data can help doctors and patients better manage type 2 diabetes. It is for people who already use insulin and a CGM device to check their blood sugar levels.
Minneapolis, MinnesotaAges 18–75 - NCT07312136Enrolling by invitation
Liver health follow-up in type 2 diabetes
This study follows up on people who already joined the EPSONIP trial to check how their liver health (MASLD) has changed over time. It uses MRI to look at the liver and does not test any new medicine.
Linköping, Östergötland CountyAges 18 years+ - NCT07019649Enrolling by invitation
AYUDA program for younger Latinx adults with type 2 diabetes
This study tests a program called AYUDA, which sends helpful text messages and support to younger Latinx adults (ages 18–44) who were recently diagnosed with type 2 diabetes and are raising children. The goal is to see if this program helps manage diabetes better.
Pleasanton, CaliforniaAges 18–44 - NCT06924697Enrolling by invitation
Testing a diabetes drug to help men quit smoking
This study tests if a medication used for type 2 diabetes (GLP-1 receptor agonists) can also reduce smoking in men with diabetes who smoke. If you qualify, you may receive this drug or a standard diabetes pill to see if it helps you smoke less.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06895018Enrolling by invitation
Grape Drink Trial for Diabetes and Fatty Liver
This study tests a drink made from grape pomace (a natural byproduct) that is rich in polyphenols—compounds that may help the liver and heart. Participants have type 2 diabetes and mild fatty liver, and researchers want to see if the drink improves liver health, blood sugar, and gut bacteria over several months.
NaplesAges 35–70 - NCT06846138Enrolling by invitation
Herbal supplement to help metformin work better and cause fewer side effects
This study tests a special herbal blend added to metformin to see if it helps reduce stomach problems and improves blood sugar control in people with type 2 diabetes. Researchers want to understand how the herbs affect the bacteria in your gut.
RigaAges 25–80 - NCT06804187Enrolling by invitation
Sweet taste and type 2 diabetes study
This study looks at how sweet taste is sensed in people with type 2 diabetes, prediabetes, or no diabetes. It involves taste tests and possibly brain scans (MRI) to help understand why people with diabetes may perceive sweetness differently.
Nottingham, East MidlandsAges 18–60
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,192 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.